Josh Zwagil Transfers AkashX Ownership to Conectiv
In a significant move for the MLM sector, Josh Zwagil has sold his AkashX business to Conectiv, just seven months after parting ways with My Daily Choice in a deal with Immunotec. This transition, announced by Investview on May 18, marks a new chapter for both Zwagil and the AkashX community.
What Led to This Transition?
AkashX was previously launched under the umbrella of My Daily Choice but was not included in the Immunotec acquisition. The absence of clear communication about My Daily Choice's acquisition raised eyebrows among industry followers. In a puzzling turn, My Daily Choice began withholding commissions from its promoters unless they transitioned to Immunotec products, creating uncertainty around the company's direction.
This lack of transparency is notable. Neither Immunotec nor My Daily Choice has formally disclosed the terms of their acquisition, adding to the confusion in the MLM community. Although the My Daily Choice website has been disabled, no mention of the Immunotec acquisition has surfaced.
New Beginnings for AkashX
With the sale to Conectiv, Zwagil is set to reposition AkashX within a more compatible framework. Chad Garner, President of Conectiv, expressed enthusiasm about the acquisition, stating, "We are thrilled to welcome Josh and the AkashX community to Conectiv." This sentiment indicates a positive outlook for the future of the AkashX platform under new ownership.
Historically, AkashX has faced challenges, particularly with allegations related to securities fraud that surfaced in 2020. In May 2025, New Zealand issued a warning regarding AkashX's practices, making the urgency for a strategic realignment even more pressing.
Conectiv's Track Record
While this acquisition may seem like a natural fit for Zwagil, it's essential to consider Conectiv’s own history. Investview has faced scrutiny for its involvement in commodities and securities fraud in both the U.S. and Canada. An example of this is their recent $4 million fine from Poland for pyramid fraud linked to iGenius, which rebranded as Conectiv in December 2025, likely in an effort to distance itself from past controversies.
The timing of this acquisition is also telling. AkashX's website has seen a decline in traffic, with only about 26,500 monthly visits as of April 2026. The majority of this traffic originates from the U.S. (86%), with smaller percentages from Italy (5%) and Colombia (4%). This decline raises questions about the efficacy of AkashX's strategies moving forward.
What This Means for the MLM Community
The acquisition is significant for distributors and consumers alike. For distributors, this transition could represent an opportunity to align with a more stable company, provided Conectiv can overcome its past issues. Consumers may also benefit if AkashX revitalizes its offerings under this new leadership.
As this story develops, industry observers will be keenly watching how Conectiv integrates AkashX into its platform and what strategies are employed to revitalize the brand.
What to Watch For Next
Looking ahead, it will be crucial to monitor whether Conectiv can successfully address its past issues and how it plans to rejuvenate the AkashX brand. The reactions from distributors, as well as any new developments concerning Immunotec and My Daily Choice, will also provide valuable insights into the evolving landscape of the MLM industry.
